NCT00032981

Brief Summary

The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
561

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started May 2001

Typical duration for phase_3

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2001

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2002

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2004

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2004

Completed
Last Updated

January 12, 2017

Status Verified

April 1, 2010

Enrollment Period

3.3 years

First QC Date

April 5, 2002

Last Update Submit

January 11, 2017

Conditions

Substance-Related Disorders

Keywords

substance use disorder

Outcome Measures

Primary Outcomes (4)

  • Drug use

  • Retention

  • HIV risk behaviors

  • Psychosocial functioning

Interventions

Behavior TherapyBEHAVIORAL

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals will be eligible for the protocol who:
  • Are seeking outpatient treatment for any substance use disorder
  • Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped)
  • Are able to understand and provide written informed consent

You may not qualify if:

  • Individuals will be excluded who:
  • Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment
  • Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Haight Ashbury Free Clinics

San Francisco, California, 94117, United States

Location

Tarzana Treatment Center

Tarzana, California, 91356, United States

Location

CT Renaissance, Inc.

Norwalk, Connecticut, 06852, United States

Location

LMG Programs, Inc.

Stamford, Connecticut, 06901, United States

Location

Rehab After Work

Philadelphia, Pennsylvania, 19103, United States

Location

Northeast Treatment Center

Philadelphia, Pennsylvania, 19123, United States

Location

Related Links

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Behavior Therapy

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Kathleen Carroll, Ph.D.

    VA Connecticut Healthcare System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Purpose
TREATMENT
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 5, 2002

First Posted

April 8, 2002

Study Start

May 1, 2001

Primary Completion

August 1, 2004

Study Completion

August 1, 2004

Last Updated

January 12, 2017

Record last verified: 2010-04

Locations

US(6)